These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1016 related items for PubMed ID: 18000798

  • 21. The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer.
    Lee AY.
    Thromb Res; 2007; 120 Suppl 2():S121-7. PubMed ID: 18023705
    [Abstract] [Full Text] [Related]

  • 22. Treatment of venous thromboembolism in cancer patients.
    Levine MN, Lee AY.
    Semin Thromb Hemost; 1999; 25(2):245-9. PubMed ID: 10357092
    [Abstract] [Full Text] [Related]

  • 23. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
    Pangilinan JM.
    J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M, Desruennes E, Di Palma M.
    Bull Cancer; 2006 Mar 01; 93(3):271-81. PubMed ID: 16567314
    [Abstract] [Full Text] [Related]

  • 25. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
    Tran QN.
    Am J Hosp Palliat Care; 2010 Sep 01; 27(6):416-9. PubMed ID: 20197558
    [Abstract] [Full Text] [Related]

  • 26. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
    Soto-Cárdenas MJ, Pelayo-García G, Rodríguez-Camacho A, Segura-Fernández E, Mogollo-Galván A, Giron-Gonzalez JA.
    Palliat Med; 2008 Dec 01; 22(8):965-8. PubMed ID: 18952751
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Managing cancer-related venous thromboembolic disease: low-molecular-weight heparins and beyond.
    O'Connell CL, Liebman HA.
    Expert Rev Hematol; 2008 Dec 01; 1(2):175-82. PubMed ID: 21082922
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.
    Clin Ther; 2007 Nov 01; 29(11):2395-405. PubMed ID: 18158080
    [Abstract] [Full Text] [Related]

  • 34. [Venous thromboembolism prophylaxis in internal medicine].
    Malý J, Widimský J, Dulícek P.
    Vnitr Lek; 2009 Mar 01; 55(3):190-5. PubMed ID: 19378845
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Anticoagulation in the treatment of established venous thromboembolism in patients with cancer.
    Lee AY.
    J Clin Oncol; 2009 Oct 10; 27(29):4895-901. PubMed ID: 19738121
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.